FDA Will Approve COVID-19 Vaccine
Digest more
Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win approval in adults aged 50 and older in November 2025. However, at the start of May, Moderna pushed back the expected approval date to 2026 after the FDA asked to see phase 3 efficacy before making a decision on authorization.
The article summarizes recent health news, highlighting Mexico's suspension of poultry imports from Brazil due to bird flu, FDA's conditions on the Novavax COVID vaccine, and the approval of Amneal’s migraine treatment.
WASHINGTON (AP) — The Trump administration’s effort ... which strain to target — just like flu vaccines. The FDA was on track to grant Novavax full approval by its April 1 target date ...
FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the ... much like how flu shots are ...